173 related articles for article (PubMed ID: 20657812)
1. Biomarkers in Barrett's Esophagus.
Souza RF
Tech Gastrointest Endosc; 2010 Apr; 12(2):116-1212. PubMed ID: 20657812
[TBL] [Abstract][Full Text] [Related]
2. Endoscopic surveillance in Barrett's esophagus.
Lunedei V; Bazzoli F; Pozzato P; De Luca L; Zagari RM; Fossi S; Ricciardiello L; Maltoni S; Roda E
Minerva Gastroenterol Dietol; 2002 Jun; 48(2):63-71. PubMed ID: 16489297
[TBL] [Abstract][Full Text] [Related]
3. Biomarkers in Barrett's esophagus.
Reid BJ; Blount PL; Rabinovitch PS
Gastrointest Endosc Clin N Am; 2003 Apr; 13(2):369-97. PubMed ID: 12916666
[TBL] [Abstract][Full Text] [Related]
4. Biomarkers of Barrett's Esophagus: From the Laboratory to Clinical Practice.
Konda VJA; Souza RF
Dig Dis Sci; 2018 Aug; 63(8):2070-2080. PubMed ID: 29713984
[TBL] [Abstract][Full Text] [Related]
5. Large intra- and inter-individual variability of genes expression levels limits potential predictive value of molecular diagnosis of dysplasia in Barrett's esophagus.
Hennig EE; Mikula M; Orlowska J; Jarosz D; Bielasik A; Regula J; Ostrowski J
J Mol Med (Berl); 2008 Feb; 86(2):233-42. PubMed ID: 17952395
[TBL] [Abstract][Full Text] [Related]
6. Diagnosis and Management of Low-Grade Dysplasia in Barrett's Esophagus: Expert Review From the Clinical Practice Updates Committee of the American Gastroenterological Association.
Wani S; Rubenstein JH; Vieth M; Bergman J
Gastroenterology; 2016 Nov; 151(5):822-835. PubMed ID: 27702561
[TBL] [Abstract][Full Text] [Related]
7. Molecular biomarkers and ablative therapies for Barrett's esophagus.
Chisholm JA; Mayne GC; Hussey DJ; Watson DI
Expert Rev Gastroenterol Hepatol; 2012 Sep; 6(5):567-81. PubMed ID: 23061708
[TBL] [Abstract][Full Text] [Related]
8. Surveillance in Barrett's esophagus: an audit of practice.
Ajumobi A; Bahjri K; Jackson C; Griffin R
Dig Dis Sci; 2010 Jun; 55(6):1615-21. PubMed ID: 19669878
[TBL] [Abstract][Full Text] [Related]
9. Surveillance in Barrett's esophagus: a failed premise.
Inadomi JM
Keio J Med; 2009 Mar; 58(1):12-8. PubMed ID: 19398879
[TBL] [Abstract][Full Text] [Related]
10. Telomerase reverse transcriptase expression is increased early in the Barrett's metaplasia, dysplasia, adenocarcinoma sequence.
Lord RV; Salonga D; Danenberg KD; Peters JH; DeMeester TR; Park JM; Johansson J; Skinner KA; Chandrasoma P; DeMeester SR; Bremner CG; Tsai PI; Danenberg PV
J Gastrointest Surg; 2000; 4(2):135-42. PubMed ID: 10675236
[TBL] [Abstract][Full Text] [Related]
11. Reflux control is important in the management of Barrett's Esophagus: results from a retrospective 1,830 patient cohort.
Brown CS; Lapin B; Wang C; Goldstein JL; Linn JG; Denham W; Haggerty SP; Talamonti MS; Howington JA; Carbray J; Ujiki MB
Surg Endosc; 2015 Dec; 29(12):3528-34. PubMed ID: 25676204
[TBL] [Abstract][Full Text] [Related]
12. Screening and surveillance for complications related to gastroesophageal reflux disease.
Spechler SJ
Am J Med; 2001 Dec; 111 Suppl 8A():130S-136S. PubMed ID: 11749938
[TBL] [Abstract][Full Text] [Related]
13. Outcomes of Radiofrequency Ablation for Dysplastic Barrett's Esophagus: A Comprehensive Review.
Luigiano C; Iabichino G; Eusebi LH; Arena M; Consolo P; Morace C; Opocher E; Mangiavillano B
Gastroenterol Res Pract; 2016; 2016():4249510. PubMed ID: 28070182
[TBL] [Abstract][Full Text] [Related]
14. An economic analysis of endoscopic ablative therapy for management of nondysplastic Barrett's esophagus.
Das A; Wells C; Kim HJ; Fleischer DE; Crowell MD; Sharma VK
Endoscopy; 2009 May; 41(5):400-8. PubMed ID: 19418393
[TBL] [Abstract][Full Text] [Related]
15. Predicting Progression in Barrett's Esophagus: Development and Validation of the Barrett's Esophagus Assessment of Risk Score (BEAR Score).
Brown CS; Lapin B; Goldstein JL; Linn JG; Talamonti MS; Carbray J; Ujiki MB
Ann Surg; 2018 Apr; 267(4):716-720. PubMed ID: 28230661
[TBL] [Abstract][Full Text] [Related]
16. A Tissue Systems Pathology Assay for High-Risk Barrett's Esophagus.
Critchley-Thorne RJ; Duits LC; Prichard JW; Davison JM; Jobe BA; Campbell BB; Zhang Y; Repa KA; Reese LM; Li J; Diehl DL; Jhala NC; Ginsberg G; DeMarshall M; Foxwell T; Zaidi AH; Lansing Taylor D; Rustgi AK; Bergman JJ; Falk GW
Cancer Epidemiol Biomarkers Prev; 2016 Jun; 25(6):958-68. PubMed ID: 27197290
[TBL] [Abstract][Full Text] [Related]
17. Biomarkers and molecular imaging in gastrointestinal cancers.
Xian W; McKeon F; Ho KY
Clin Gastroenterol Hepatol; 2014 Jan; 12(1):126-9. PubMed ID: 23978343
[TBL] [Abstract][Full Text] [Related]
18. Impact of advanced endoscopic imaging on Barrett's esophagus in daily clinical practice.
Beg S; Mensa M; Fullard M; Finerty E; Richman P; Leahy A
Gastrointest Endosc; 2018 May; 87(5):1189-1194. PubMed ID: 28958906
[TBL] [Abstract][Full Text] [Related]
19. The diagnosis and management of Barrett's esophagus.
DeMeester SR; DeMeester TR
Adv Surg; 1999; 33():29-68. PubMed ID: 10572561
[TBL] [Abstract][Full Text] [Related]
20. A genomic biomarker-based model for cancer risk stratification of non-dysplastic Barrett's esophagus patients after extended follow up; results from Dutch surveillance cohorts.
Hoefnagel SJM; Mostafavi N; Timmer MR; Lau CT; Meijer SL; Wang KK; Krishnadath KK
PLoS One; 2020; 15(4):e0231419. PubMed ID: 32282835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
